BUY Divi's Laboratories Limited — Somil Mehta, Sharekhan
bySomil Mehta, SharekhanHorizon: NA (inferred Swing (≤2wk))27 Oct 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
3 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·30 Oct · today
Divi's Laboratories shares in focus as weight loss drug receives EU panel backing
NewsCnbc-Tv18·19 Oct · 2w ago
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·26 Aug · 2mo ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Divi's Laboratories
- BUY — Chandan Taparia, Motilal Oswal13 Nov 2026 · ~2 weeks · target ₹12,400 · Active
- BUY — Nuvama Wealth9 Nov 2026 · ~1 year · target ₹12,000 · Active
- BUY — Jefferies India9 Nov 2026 · ~1 year · target ₹12,550 · Active
- BUY — Morgan Stanley9 Nov 2026 · ~1 year · target ₹11,359 · Target hit
- SELL — Elara Capital9 Nov 2026 · ~1 year · target ₹6,539 · Active
More from Somil Mehta, Sharekhan
- BUY GE Vernova T&D India13 Nov 2026 · ~2 weeks · target ₹4,790 · Active
- BUY Eicher Motors13 Nov 2026 · ~2 weeks · target ₹8,000 · Active
- BUY TBO Tek12 Nov 2026 · ~2 weeks · target ₹1,750 · Active
- BUY Max Healthcare Institute12 Nov 2026 · ~2 weeks · target ₹1,000 · Active
- BUY Kalyan Jewellers India12 Nov 2026 · ~2 weeks · target ₹800 · Active

